Merck & Co.Grant
Merck Sharp & Dohme granted patent for plasma kallikrein inhibitors.
The filing
Merck Sharp & Dohme LLC was granted US patent 12790312 for plasma kallikrein inhibitors on November 10, 2026. The patent is titled "PLASMA KALLIKREIN INHIBITORS" and is available at 12790312 (opens in a new tab).
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.